Terns Pharmaceuticals, Inc. (TERN)

39.26 -1.14 (-2.82%) USD  |  NASDAQ  |  Jan 02, 13:38
More

Terns Pharmaceuticals Change in Receivables (Quarterly)

Change in Receivables (Quarterly) Chart

View Change in Receivables (Quarterly) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Receivables (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Receivables (Quarterly) Range, Past 5 Years

View Change in Receivables (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Receivables (Quarterly) Benchmarks

View Change in Receivables (Quarterly) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. --
Cidara Therapeutics, Inc. Upgrade